This platform used know preclinical in vitro and in vivo datasets to simulate systemic therapy and site-of-action penetration of the calcium channel blockers and angiotensin-converting enzyme compounds to tissues implicated in the pathogenesis of COVID19. Here, ACE is linked to COVID-19.